Cargando…
Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications
Multiple system atrophy (MSA) is a fatal rapidly progressive α-synucleinopathy, characterized by α-synuclein accumulation in oligodendrocytes. It is accepted that the pathological α-synuclein accumulation in the brain of MSA patients plays a leading role in the disease process, but little is known a...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786272/ https://www.ncbi.nlm.nih.gov/pubmed/26962858 http://dx.doi.org/10.1371/journal.pone.0150705 |
_version_ | 1782420528764551168 |
---|---|
author | Schafferer, Simon Khurana, Rimpi Refolo, Violetta Venezia, Serena Sturm, Edith Piatti, Paolo Hechenberger, Clara Hackl, Hubert Kessler, Roman Willi, Michaela Gstir, Ronald Krogsdam, Anne Lusser, Alexandra Poewe, Werner Wenning, Gregor K. Hüttenhofer, Alexander Stefanova, Nadia |
author_facet | Schafferer, Simon Khurana, Rimpi Refolo, Violetta Venezia, Serena Sturm, Edith Piatti, Paolo Hechenberger, Clara Hackl, Hubert Kessler, Roman Willi, Michaela Gstir, Ronald Krogsdam, Anne Lusser, Alexandra Poewe, Werner Wenning, Gregor K. Hüttenhofer, Alexander Stefanova, Nadia |
author_sort | Schafferer, Simon |
collection | PubMed |
description | Multiple system atrophy (MSA) is a fatal rapidly progressive α-synucleinopathy, characterized by α-synuclein accumulation in oligodendrocytes. It is accepted that the pathological α-synuclein accumulation in the brain of MSA patients plays a leading role in the disease process, but little is known about the events in the early stages of the disease. In this study we aimed to define potential roles of the miRNA-mRNA regulatory network in the early pre-motor stages of the disease, i.e., downstream of α-synuclein accumulation in oligodendroglia, as assessed in a transgenic mouse model of MSA. We investigated the expression patterns of miRNAs and their mRNA targets in substantia nigra (SN) and striatum, two brain regions that undergo neurodegeneration at a later stage in the MSA model, by microarray and RNA-seq analysis, respectively. Analysis was performed at a time point when α-synuclein accumulation was already present in oligodendrocytes at neuropathological examination, but no neuronal loss nor deficits of motor function had yet occurred. Our data provide a first evidence for the leading role of gene dysregulation associated with deficits in immune and inflammatory responses in the very early, non-symptomatic disease stages of MSA. While dysfunctional homeostasis and oxidative stress were prominent in SN in the early stages of MSA, in striatum differential gene expression in the non-symptomatic phase was linked to oligodendroglial dysfunction, disturbed protein handling, lipid metabolism, transmembrane transport and altered cell death control, respectively. A large number of putative miRNA-mRNAs interaction partners were identified in relation to the control of these processes in the MSA model. Our results support the role of early changes in the miRNA-mRNA regulatory network in the pathogenesis of MSA preceding the clinical onset of the disease. The findings thus contribute to understanding the disease process and are likely to pave the way towards identifying disease biomarkers for early diagnosis of MSA. |
format | Online Article Text |
id | pubmed-4786272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47862722016-03-23 Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications Schafferer, Simon Khurana, Rimpi Refolo, Violetta Venezia, Serena Sturm, Edith Piatti, Paolo Hechenberger, Clara Hackl, Hubert Kessler, Roman Willi, Michaela Gstir, Ronald Krogsdam, Anne Lusser, Alexandra Poewe, Werner Wenning, Gregor K. Hüttenhofer, Alexander Stefanova, Nadia PLoS One Research Article Multiple system atrophy (MSA) is a fatal rapidly progressive α-synucleinopathy, characterized by α-synuclein accumulation in oligodendrocytes. It is accepted that the pathological α-synuclein accumulation in the brain of MSA patients plays a leading role in the disease process, but little is known about the events in the early stages of the disease. In this study we aimed to define potential roles of the miRNA-mRNA regulatory network in the early pre-motor stages of the disease, i.e., downstream of α-synuclein accumulation in oligodendroglia, as assessed in a transgenic mouse model of MSA. We investigated the expression patterns of miRNAs and their mRNA targets in substantia nigra (SN) and striatum, two brain regions that undergo neurodegeneration at a later stage in the MSA model, by microarray and RNA-seq analysis, respectively. Analysis was performed at a time point when α-synuclein accumulation was already present in oligodendrocytes at neuropathological examination, but no neuronal loss nor deficits of motor function had yet occurred. Our data provide a first evidence for the leading role of gene dysregulation associated with deficits in immune and inflammatory responses in the very early, non-symptomatic disease stages of MSA. While dysfunctional homeostasis and oxidative stress were prominent in SN in the early stages of MSA, in striatum differential gene expression in the non-symptomatic phase was linked to oligodendroglial dysfunction, disturbed protein handling, lipid metabolism, transmembrane transport and altered cell death control, respectively. A large number of putative miRNA-mRNAs interaction partners were identified in relation to the control of these processes in the MSA model. Our results support the role of early changes in the miRNA-mRNA regulatory network in the pathogenesis of MSA preceding the clinical onset of the disease. The findings thus contribute to understanding the disease process and are likely to pave the way towards identifying disease biomarkers for early diagnosis of MSA. Public Library of Science 2016-03-10 /pmc/articles/PMC4786272/ /pubmed/26962858 http://dx.doi.org/10.1371/journal.pone.0150705 Text en © 2016 Schafferer et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Schafferer, Simon Khurana, Rimpi Refolo, Violetta Venezia, Serena Sturm, Edith Piatti, Paolo Hechenberger, Clara Hackl, Hubert Kessler, Roman Willi, Michaela Gstir, Ronald Krogsdam, Anne Lusser, Alexandra Poewe, Werner Wenning, Gregor K. Hüttenhofer, Alexander Stefanova, Nadia Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications |
title | Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications |
title_full | Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications |
title_fullStr | Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications |
title_full_unstemmed | Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications |
title_short | Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications |
title_sort | changes in the mirna-mrna regulatory network precede motor symptoms in a mouse model of multiple system atrophy: clinical implications |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786272/ https://www.ncbi.nlm.nih.gov/pubmed/26962858 http://dx.doi.org/10.1371/journal.pone.0150705 |
work_keys_str_mv | AT schafferersimon changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT khuranarimpi changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT refolovioletta changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT veneziaserena changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT sturmedith changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT piattipaolo changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT hechenbergerclara changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT hacklhubert changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT kesslerroman changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT willimichaela changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT gstirronald changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT krogsdamanne changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT lusseralexandra changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT poewewerner changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT wenninggregork changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT huttenhoferalexander changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications AT stefanovanadia changesinthemirnamrnaregulatorynetworkprecedemotorsymptomsinamousemodelofmultiplesystematrophyclinicalimplications |